Skip to main content
    E

    Ensysce Biosciences Inc (ENSC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.42
    +0.03 (+8.06%)

    Market Cap: $8.14M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(14/21)
    Avg Surprise
    +17.50%
    Streak
    4 Q

    Upcoming Estimates

    Reports Mar 29, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.08
    Range-$0.14 - -$0.01
    4 analysts
    Revenue Consensus
    $901.00K
    RangeN/A
    5 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-280.50%Operating Margin-281.30%
    ROE-1295.00%ROIC-260.55%
    Financial Health
    Debt/Equity0.01xInterest Coverage-7126.08x
    Current Ratio8.02xQuick Ratio8.02x
    Trading Statistics
    Beta1.09Avg Volume306.85K
    52-Week High$2.0452-Week Low$0.23

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 6.2% below its 50-day moving average, and the 50-day average is above the 200-day average. The 14-day RSI is 50.1, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$0.37
    SMA 20$0.42
    SMA 50$0.45
    SMA 200$0.41
    EMA 10$0.39
    EMA 20$0.41
    EMA 50$0.42
    EMA 200$0.60

    MACD

    Line: -0.02Signal: -0.02Hist: -0.00

    ADX

    ADX: 23.6+DI: 21.4-DI: 20.1

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down80.0
    PSAR$0.30

    Bollinger Bands

    Upper Band$0.54
    Lower Band$0.30
    %B Position5611%(Upper)
    Band Width0.49

    RSI (14-Day)

    Neutral
    50.1

    Momentum Oscillators

    Stoch %K47.0
    Stoch %D34.6
    Williams %R-31.6
    ROC (10d)-0.6%
    Momentum-0.00
    CCI (20d)-10.2
    MFI (14d)32.1

    Volatility Measures

    ATR (14d)$0.05(11.6%)
    StdDev (20d)0.06
    Hist Vol82.9%(High)

    Volume Flow

    VWAP$0.42
    OBV1.2B
    AD Line-480.3M
    CMF (20d)-0.302

    Volume Metrics

    Avg Vol (20d)296.2K
    Vol Ratio1.4x
    VWMA (20d)$0.42

    Pivot Points

    R3$0.47
    R2$0.45
    R1$0.42
    Pivot Point$0.40
    S1$0.37
    S2$0.35
    S3$0.32

    Advanced Oscillators

    TSI-18.27
    Ultimate Osc47.4
    KST-187.47

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about ENSC

    News

    ENSC Valuation

    Ensysce Biosciences (ENSC) trades at 0.9x forward earnings.

    Forward P/E
    0.9x
    P/B
    0.3x
    ENSC valuation multiples

    ENSC Profitability: Margins, ROIC and FCF

    Ensysce Biosciences (ENSC) has a gross margin of -1326.6%, an operating margin of -281.3% and a net margin of -280.5%. It posts -260.6% ROIC and a -138.3% FCF margin.

    Gross margin
    -1326.6%
    Operating margin
    -281.3%
    Net margin
    -280.5%
    ROIC
    -260.6%
    ROE
    -1295.0%
    FCF margin
    -138.3%
    ENSC financial statements

    Ensysce Biosciences Competitors

    The companies most similar to Ensysce Biosciences (ENSC) include Dare Bioscience, Exicure and Soligenix.

    Sector: Healthcare

    Companies most similar to Ensysce Biosciences

    ENSC Bull Case vs Bear Case

    Bull case

    • ENSC beat EPS estimates in 75.0% of its last 8 reported quarters.

    Bear case

    • ENSC has a -280.5% net profit margin.
    • ENSC's quarterly revenue changed -15.1% year over year.

    ENSC Earnings: Beat Rate and Next Report

    Ensysce Biosciences (ENSC) beat the EPS estimate in 6 of the last 8 quarters (75.0%). Its next report is expected on Mar 29, 2027.

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    15.1%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.08
    ENSC earnings history

    ENSC Earnings Date

    ENSC reports Mar 29, 2027. The date is estimated.

    Updated Nov 14, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About ENSC

    When does ENSC report earnings?

    Ensysce Biosciences Inc (ENSC) is expected to report earnings on Mar 29, 2027.

    Does ENSC pay dividends?

    Ensysce Biosciences Inc (ENSC) does not currently pay a regular dividend.

    What is ENSC's market cap?

    Ensysce Biosciences Inc (ENSC) has a market capitalization of $8.14M with a current stock price of $0.42.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.